Tesofensine Tesofensine is a triple monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine) that increases energy expenditure and enhances fat oxidation
A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity
The gap between what regulatory announcements claim and what patients actually experience comes down to three things most coverage never mentions: the legal threshold for shortage designation, the economics of compounding pharmacy operations, and the practical timeline for patient transitions
Hamal S, Cherukuri L, Shaikh K, Kinninger A, Doshi J, Birudaraju D et al (2020) Effect of semaglutide on coronary atherosclerosis progression in patients with type II diabetes: rationale and design of the semaglutide treatment on coronary progression trial
Understand the trendlines for oral dutasteride: when results will typically first start to show, when results will peak and/or plateau, and what results will look like 5+ years into the future
External sources do not endorse this website